EUCTR2005-002398-57-IT进行中（未招募）不适用
A randomized, double-blind, parallel-group, multicenter study to demonstrate improvement in symptoms of constipation in subjects with non-malignant pain taking oxycodone equivalent of lt; 20 mg/day and gt; 50 mg/day as oxycodone / naloxone prolonged release compared to subjects taking oxycodone prolonged release tablets alone.
MUNDIPHARMA RESEARCH GMBH CO. KG0 个研究点开始时间: 2007年2月27日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Assess safety and efficacy of vilaprisan in subjects with endometriosisPre-menopausal women 18 years and older with confirmed endometriosis and moderate to severe endometriosis-associated pelvic pain (EAPP), otherwise in good general health.MedDRA version: 20.0Level: PTClassification code 10014778Term: EndometriosisSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2013-004768-72-DEBayer AG315
进行中（未招募）
1 期
Study of safety, tolerability and efficacy of a combination treatment of tropifexor (LJN452) & licogliflozin (LIK066) in adult patients with nonalcoholic steatohepatitis (NASH) and liver fibrosisEUCTR2019-002324-32-ITOVARTIS PHARMA AG233
进行中（未招募）
1 期
Assess safety and efficacy of vilaprisan in subjects with endometriosisEUCTR2013-004768-72-ESBayer AG315
进行中（未招募）
1 期
Assess safety and efficacy of vilaprisan in subjects with endometriosisPre-menopausal women 18 years and older with confirmed endometriosis and moderate to severe endometriosis-associated pelvic pain (EAPP), otherwise in good general health.MedDRA version: 20.0Level: PTClassification code 10014778Term: EndometriosisSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2013-004768-72-SEBayer AG315
进行中（未招募）
1 期
Study of safety, tolerability and efficacy of a combination treatment oftropifexor (LJN452) & licogliflozin (LIK066) compared to eachmonotherapy, compared with placebo in adult participants withnonalcoholic steatohepatitis (NASH) and liver fibrosison-alcoholic Steatohepatitis (NASH)MedDRA version: 24.1Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2019-002324-32-DKovartis Pharma AG380